Insulin Lispro
Links shared publicly online about this topic
Results Of Linjeta™ Study Versus Insulin Lispro Reported In The Platform Presentation At EASD Annual Meeting
medicalnewstoday.com — “In a platform presentation at the 46th annual meeting of the European Association for the Study of Diabetes (EASD) in Stockholm, investigators for Biodel Inc. (Nasdaq: BIOD) presented the results” View full resource at medicalnewstoday.com
Most Recently Shared on September 22, 2010 at 3:50 pm By:
Scott Strumello Patient Expert
RT @mnt_diabetes Results Of Linjetaâ„¢ Study vs. Insulin Lispro Reported In The Platform Presentation at EASD Meeting http://bit.ly/cjHdmT
DURABLE trial: Twice-daily insulin lispro mix improved glycemic control
endocrinetoday.com — “New data from the DURABLE trial support the concept of earlier insulin initiation. Compared with insulin glargine, patients with type 2 diabetes” View full resource at endocrinetoday.com
Most Recently Shared on March 31, 2011 at 8:59 pm By:
DURABLE trial: Twice-daily insulin lispro mix improved glycemic control http://bit.ly/gsX7R2
Humalog (insulin lispro injection [rDNA origin]) | Learn About Humalog
humalog.com — “Learn about Humalog.” View full resource at humalog.com
Most Recently Shared on May 4, 2010 at 5:22 pm By:
Diabetes drug Humalog, a mealtime insulin medication http://bit.ly/daiXtT #diabetestype2
Humalog (insulin lispro injection [rDNA origin]) | Humalog Side Effects
humalog.com — “Learn about the most common side effects of Humalog.” View full resource at humalog.com
Most Recently Shared on May 4, 2010 at 5:24 pm By:
Are there any side effects of diabetes drug Humalog? http://bit.ly/cLSfJQ #diabetestype2
Halozyme Study Results Demonstrate Significantly Less Absorption Variability For Insulin Lispro Administered With PH20 Enzyme
medicalnewstoday.com — “Halozyme therapeutics, inc. (nasdaq:halo) announced insulin variability study results that demonstrated reduced intrasubject absorption variability for the combination of lispro, a meal time analo” View full resource at medicalnewstoday.com
Most Recently Shared on November 9, 2009 at 4:55 pm By:
Halozyme Study Results Demonstrate Significantly Less Absorption Variability For Insulin Lispro Administered Wi.. http://bit.ly/ActbN
FDA Approves Updates To Lilly's Humalog® (insulin Lispro Injection [rDNA Origin]) Label
medicalnewstoday.com — “Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration (FDA) approved the company's supplemental new drug application (sNDA) with the following updates to the Humal” View full resource at medicalnewstoday.com
Most Recently Shared on June 9, 2011 at 7:05 am By:
MNT Drug Approvals Health News
FDA Approves Updates To Lilly's Humalog® (insulin Lispro Injection [rDNA Origin]) Label http://mnt.to/3WXv #regulatory
Humalog (insulin lispro injection [rDNA origin] | How to Take Humalog
humalog.com — “Learn how to take Humalog.” View full resource at humalog.com
Most Recently Shared on May 4, 2010 at 5:23 pm By:
How do you take Humalog? http://bit.ly/d49daG #diabetestype2
FDA Approves Updates to Lilly's Humalog® (insulin lispro injection [rDNA origin]) Label -- INDIANAPOLIS, June 8, 2011 /PRNewswire/ --
prnewswire.com — “FDA Approves Updates to Lilly's Humalog® (insulin lispro injection [rDNA origin]) Label. Update for Insulin Pump Use Provides an Additional Option for Children With Type 1 Diabetes and Extends Amount of Time People Can Use and Store Humalog Insulin in Their Pumps.” View full resource at prnewswire.com
Most Recently Shared on June 8, 2011 at 1:02 pm By:
Kelly / Diabetes Patient Expert
Humalog OK'd in pumps for 7 days & for pumper kids 4+ with type 1 diabetes: http://prn.to/irk0tV
Biodel Corporation - Results of Linjeta(TM) Study Versus Insulin Lispro Reported Today in Platform Presentation at EASD Annual Meeting
investor.biodel.com — “Biodel Corporation - Results of Linjeta(TM) Study Versus Insulin Lispro Reported Today in Platform Presentation at EASD Annual Meeting” View full resource at investor.biodel.com
Most Recently Shared on September 21, 2010 at 1:11 pm By:
Scott Strumello Patient Expert
Biodel Results of Linjeta Study Versus Insulin Lispro Reported Today in Platform Presentation at EASD Meeting: http://bit.ly/dzNg7i
Eli Lilly and Company - FDA Approves Updates to Lilly's Humalog® (insulin lispro injection [rDNA origin]) Label
newsroom.lilly.com — “Eli Lilly and Company - FDA Approves Updates to Lilly's Humalog® (insulin lispro injection [rDNA origin]) Label” View full resource at newsroom.lilly.com
Most Recently Shared on June 8, 2011 at 10:31 pm By:
FDA Approves Updates to Lilly's Humalog® (insulin lispro injection [rDNA origin]) Label http://bit.ly/jZ4a7v
FDA Approves Updates To Lilly’s Humalog® (insulin Lispro Injection [rDNA Origin]) Label | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com
keyvive.com — “FDA Approves Updates To Lilly’s Humalog® (insulin Lispro Injection [rDNA Origin]) Label | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com” View full resource at keyvive.com
Most Recently Shared on June 9, 2011 at 2:34 pm By:
FDA Approves Updates To Lilly’s Humalog® (insulin Lispro Injection [rDNA Origin]) Label: Eli… http://goo.gl/fb/HdrQt
Halozyme Begins Phase 2 Clinical Trials With Insulin Analogs Lispro And Aspart With RHuPH20 In Type 1 And Type 2 Diabetes
medicalnewstoday.com — “Halozyme Therapeutics, Inc. (Nasdaq: HALO) announced the initiation of two Phase 2 Ultrafast Insulin treatment studies that utilize its rHuPH20 hyaluronidase enzyme (PH20) in combination with the” View full resource at medicalnewstoday.com
Most Recently Shared on September 3, 2010 at 1:12 pm By:
Scott Strumello Patient Expert
RT @mnt_diabetes Halozyme Begins Phase 2 Clinical Trials With Insulin Analogs Lispro And Aspart Wi.. http://bit.ly/arqKXo
Halozyme’s RHuPH20 With Recombinant Human Insulin Demonstrates Glycemic Control Comparable To Lispro | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com
keyvive.com — “Halozyme’s RHuPH20 With Recombinant Human Insulin Demonstrates Glycemic Control Comparable To Lispro | Diabetes | Type 2 Diabetes | Diabetes Mellitus | Keyvive.com” View full resource at keyvive.com
Most Recently Shared on November 15, 2010 at 4:50 pm By:
Halozyme’s RHuPH20 With Recombinant Human Insulin Demonstrates Glycemic Control Comparable To… http://goo.gl/fb/niSDm
Symposier - Hyaluronidase Accelerated Insulin Absorption
symposier.com — “Uploaded and shared in Youtube by: ElsGlobalMedicalNews — Recombinant human hyaluronidase combined with human regular insulin produced comparable glycemic responses to lispro insulin in a randomized open-label crossover study of 46 patients with well-controlled type 1 diabetes. Dr. Satish Garg discusses the results. See the related story at http://tinyurl.com/6jbkbuw” View full resource at symposier.com
Most Recently Shared on July 13, 2011 at 4:34 pm By:
Symposier Endocrino Health Site
Use of Recombinant Human Hyaluronidase with Insulin, Enzime accelerates absorption of human regular insulin. http://bit.ly/pfnnkS
Insulin Glulisine Compared to Insulin Aspart and t... [Diabetes Technol Ther. 2011] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on April 7, 2011 at 3:45 am By:
Insulin Glulisine Compared to Aspart & Lispro Administered by CSII in Patients with Type 1 #Diabetes: RCT http://1.usa.gov/fX2sLy #hypoglyc
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Scott Strumello
-
Endocrine Today
The official Twitter for Endocrine Today, clinical news on diabetes and endocrine disorders.
-
Diabetes, Type 2
Organizing type 2 diabetes resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement
